Apolipoprotein(a) size polymorphism is associated with coronary heart disease in polygenic hypercholesterolemia

被引:6
作者
Emanuele, E
Peros, E
Minoretti, P
D'Angelo, A
Piccinni, MN
Montagna, L
Geroldi, D
机构
[1] Univ Pavia, IRCCS, San Matteo Hosp, Dept Internal Med & Med Therapeut, I-27100 Pavia, Italy
[2] Univ Pavia, IRCCS, San Matteo Hosp, Mol Med Lab, I-27100 Pavia, Italy
关键词
polygenic hypercholesterolemia; coronary heart disease; lipoprotein(a); apolipoprotein(a); genetic markers;
D O I
10.1016/S0939-4753(04)80004-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Aim: In addition to high serum cholesterol levels, various cardiovascular risk factors may be involved in the development of coronary heart disease (CHD) in hypercholesterolemic subjects. As the levels of lipoprotein(a) [Lp(a)], an important and independent cardiovascular risk factor, are high in polygenic hyper-cholesterolemia (PH), we investigated plasma Lp(a) levels and apolipoprotein(a) [apo(a)] phenotypes in relation to occurrence of CHD events in PH patients. Methods and Results: Lp(a) levels and apo(a) isoforms were determined in 191 PH patients, 83 normocholesterolemic subjects with CHD, and 94 normocholesterolemic controls without CHD. Lp(a) levels were similar in the hypercholesterolemic subjects with (n=100) or without CHD (n=91): 21.4 (range 66-59.23) vs 18.5 (range 5.25-57.25) mg/dL (p=NS). Low molecular weight apo (a) isoforms were more prevalent (55%) in the PH patients with CHD, whereas high molecular weight apo (a) isoforms were more prevalent (62.6%) in those without CHD: this difference was significant (p<0.05). A stepwise multiple-discriminant analysis made in order to determine the independence of common cardiovascular risk factors, Lp (a) levels and low molecular weight apo(a) isoforms in predicting CHD among hypercholesterolemic subjects showed that the presence of a positive family history of CHD, smoking, age, and the presence of at least one apo(a) isoform of low molecular weight were independently associated with CHD. Conclusions: Despite high Lp (a) levels, our findings do not support the hypothesis that Lp(a) plays an independent role in determining clinical CHD in PH subjects. However, the presence of at least one low molecular weight apo(a) isoform is an independent genetic predictor of CHD in hypercholesterolemic subjects. Together with other cardiovascular risk factors, apo (a) phenotypes should be assessed to evaluate the overall CHD risk status of all subjects with high serum cholesterol levels. Nutr Metab Cardiovasc Dis ((C))2004, Medikal Press.
引用
收藏
页码:193 / 199
页数:7
相关论文
共 38 条
[1]   Apolipoprotein(a): Structure-function relationship at the lysine-binding site and plasminogen activator cleavage site [J].
Angles-Cano, E ;
Rojas, G .
BIOLOGICAL CHEMISTRY, 2002, 383 (01) :93-99
[2]  
Anglés-Cano E, 2001, ANN NY ACAD SCI, V936, P261
[3]   LP(A) CONCENTRATION AND APO(A) ISOFORM SIZE - RELATION TO THE PRESENCE OF CORONARY-ARTERY DISEASE IN FAMILIAL HYPERCHOLESTEROLEMIA [J].
BOWDEN, JF ;
PRITCHARD, PH ;
HILL, JS ;
FROHLICH, JJ .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (10) :1561-1568
[4]   Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease [J].
Brown, BG ;
Zhao, XQ ;
Chait, A ;
Fisher, LD ;
Cheung, MC ;
Morse, JS ;
Dowdy, AA ;
Marino, EK ;
Bolson, EL ;
Alaupovic, P ;
Frohlich, J ;
Albers, JJ ;
Serafini, L ;
Huss-Frechette, E ;
Wang, S ;
DeAngelis, D ;
Dodek, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (22) :1583-1592
[5]   EPIDEMIOLOGY OF CORONARY HEART-DISEASE - THE FRAMINGHAM-STUDY [J].
CASTELLI, WP .
AMERICAN JOURNAL OF MEDICINE, 1984, 76 (2A) :4-12
[6]   Serum lipopotein (a) levels in a large sample of subjects affected by familial combined hyperlipoproteinaemia and in general population [J].
Cicero, AFG ;
Panourgia, MP ;
Linarello, S ;
D'Addato, S ;
Sangiorgi, Z ;
Gaddi, A .
JOURNAL OF CARDIOVASCULAR RISK, 2003, 10 (02) :149-151
[7]  
Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3
[8]   ASSOCIATION OF LEVELS OF LIPOPROTEIN LP(A), PLASMA-LIPIDS, AND OTHER LIPOPROTEINS WITH CORONARY-ARTERY DISEASE DOCUMENTED BY ANGIOGRAPHY [J].
DAHLEN, GH ;
GUYTON, JR ;
ATTAR, M ;
FARMER, JA ;
KAUTZ, JA ;
GOTTO, AM .
CIRCULATION, 1986, 74 (04) :758-765
[9]   CLINICAL-SIGNIFICANCE OF EXERCISE-INDUCED SILENT-MYOCARDIAL-ISCHEMIA IN PATIENTS WITH CORONARY-ARTERY DISEASE [J].
FALCONE, C ;
DESERVI, S ;
POMA, E ;
CAMPANA, C ;
SCIRE, A ;
MONTEMARTINI, C ;
SPECCHIA, G .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 9 (02) :295-299
[10]   Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age [J].
Gazzaruso, C ;
Garzaniti, A ;
Buscaglia, P ;
Bonetti, G ;
Falcone, C ;
Fratino, P ;
Finardi, G ;
Geroldi, D .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (01) :157-163